Reduced exercise capacity and impaired pulmonary function in patients with scleroderma Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010
Reference values for residual volume, functional residual capacity and total lung capacity Source: Guideline 1995 Year: 1995
A comparison between total lung capacity and effective alveolar volume in patients with restrictive lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 180s Year: 2005
Reduced aerobic capacity and increased ventilatory response during maximal exercise in patients with primary hypogonadism Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases Year: 2009
Total lung capacity (TLC) or vital capacity (VC) - which is more reduced in interstitial lung disease (ILD) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001
Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018
Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO) Source: Annual Congress 2008 - Exercise: system responses Year: 2008
Dynamic pathophysiology in stable COPD patients with severely reduced exercise capacity Source: Annual Congress 2011 - Exercise assessment in different diseases Year: 2011
Long-term CPAP-therapy increases anaerobic threshold and diffusing capacity in overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002
Maximal exercise capacity pulmonary function and fatigue in lung cancer patients with complete remission Source: International Congress 2019 – Exercise tolerance and its determinants across pathologies Year: 2019
Is inspiratory capacity (IC) better correlated with functional exercise capacity than FEV1 in COPD patients? Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012
Static lung compliance and DLCO often demonstrate parenchymal involvement in sarcoidosis despite a normal total lung capacity Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009
Impaired TF following exercise is related to reduced lung capillary blood volume but is attenuated by an increase in the lung membrane diffusion capacity Source: Eur Respir J 2003; 22: Suppl. 45, 408s Year: 2003
Peak oxygen consumption is reduced in patients with sarcoidosis and is associated with the diffusion capacity of the lung and the left ventricular function Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009
Relationship between disability, lung function and functional capacity in multiple sclerosis Source: Eur Respir J 2005; 26: Suppl. 49, 183s Year: 2005
Forced oscillation technique in patients with systemic sclerosis comparison with diffusing capacity Source: Eur Respir J 2001; 18: Suppl. 33, 204s Year: 2001
Baseline characteristics of idiopathic PAH patients with severely reduced diffusion capacity Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012
A high pulmonary capillary blood volume allows for increased aerobic exercise capacity at a lower ventilatory cost in healthy adults Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020
The change of lung diffusion capacity does not influence the prognosis in patients with pulmonary arterial hypertension associated with systemic sclerosis. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006